The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abboushi, N.
Right arrow Articles by Dbaibo, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abboushi, N.
Right arrow Articles by Dbaibo, G. S.
The Journal of Immunology, 2004, 173: 3193-3200.
Copyright © 2004 by The American Association of Immunologists

Ceramide Inhibits IL-2 Production by Preventing Protein Kinase C-Dependent NF-{kappa}B Activation: Possible Role in Protein Kinase C{theta} Regulation1

Nour Abboushi2,*, Aimee El-Hed2,*, Wissal El-Assaad{dagger}, Lina Kozhaya*, Marwan E. El-Sabban{ddagger}, Ali Bazarbachi*, Rami Badreddine*, Alicja Bielawska§, Julnar Usta* and Ghassan S. Dbaibo3,*,{dagger}

Departments of * Biochemistry, {dagger} Pediatrics, and {ddagger} Human Morphology, American University of Beirut, Faculty of Medicine, Beirut, Lebanon; and § Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC 29425

The role of the sphingolipid ceramide in modulating the immune response has been controversial, in part because of conflicting data regarding its ability to regulate the transcription factor NF-{kappa}B. To help clarify this role, we investigated the effects of ceramide on IL-2, a central NF-{kappa}B target. We found that ceramide inhibited protein kinase C (PKC)-mediated activation of NF-{kappa}B. Ceramide was found to significantly reduce the kinase activity of PKC{theta} as well as PKC{alpha}, the critical PKC isozymes involved in TCR-induced NF-{kappa}B activation. This was followed by strong inhibition of IL-2 production in both Jurkat T leukemia and primary T cells. Exogenous sphingomyelinase, which generates ceramide at the cell membrane, also inhibited IL-2 production. As expected, the repression of NF-{kappa}B activation by ceramide led to the reduction of transcription of the IL-2 gene in a dose-dependent manner. Inhibition of IL-2 production by ceramide was partially overcome when NF-{kappa}B nuclear translocation was reconstituted with activation of a PKC-independent pathway by TNF-{alpha} or when PKC{theta} was overexpressed. Importantly, neither the conversion of ceramide to complex glycosphingolipids, which are known to have immunosuppressive effects, nor its hydrolysis to sphingosine, a known inhibitor of PKC, was necessary for its inhibitory activity. These results indicate that ceramide plays a negative regulatory role in the activation of NF-{kappa}B and its targets as a result of inhibition of PKC.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
G. Yan, J. Huang, N. R. Jarbadan, Y. Jiang, and H. Cheng
Sequestration of NF-{kappa}B Signaling Complexes in Lipid Rafts Contributes to Repression of NF-{kappa}B in T Lymphocytes under Hyperthermia Stress
J. Biol. Chem., May 2, 2008; 283(18): 12489 - 12500.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.